ARTG 462415Gastro-oesophageal antireflux barrier
ARTG ID: 462415 · Aspen Pharmacare Australia Pty Ltd · DMG Italia Srl · Class IIa · Started September 19, 2024
Good Name: Aspen Pharmacare Australia Pty Ltd - Gastro-oesophageal antireflux barrier
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 462415
- Start Date
- September 19, 2024
- Effective Date
- September 19, 2024
- Name
- DMG Italia Srl
- Country
- Italy
- Address
- Via Laurentina Km 26, Pomezia, Rome, 700-00071
Oral spray intended for the temporary relief of symptoms from gastric acid reflux by the use of a protective mucoadhesive lining on the tissues of the oropharynx. This device is available [non-prescription] over-the-counter (OTC) for home use and may be used to treat gastro-oesophageal reflux disease (GERD) of various causes.
Access comprehensive regulatory information for Gastro-oesophageal antireflux barrier in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 462415 and sponsored by Aspen Pharmacare Australia Pty Ltd, manufactured by DMG Italia Srl in Italy. The device registration started on September 19, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.